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Post-traumatic endophthalmitis caused by Nocardia nova
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Abstract
Introduction. Nocardia nova complex has been associated with infections in both immunocompetent and
immunocompromised patients. Infection can be localized or disseminated, affecting skin and soft tissues, the respiratory
system, bones and joints, the circulatory system and especially the central nervous system. Ocular infections such as
keratitis, scleritis, conjunctivitis, dacryocystitis, orbital cellulitis and endophthalmitis due to Nocardia spp. are infrequently
reported, and usually described after penetrating corneal trauma or ocular contact with plants and soils.
Case presentation. An immunocompetent male presented with a history of penetrating ocular trauma that had evolved to
infectious endophthalmitis, which was refractory to different antibiotic treatments. No micro-organisms were isolated from
repeated conjunctival smear and corneal scraping cultures between the ocular trauma (August 2014) and the
endophthalmitis diagnosis (November 2015). After this period, N. nova sensu stricto was isolated in aqueous humour
aspirate. Treatment was adjusted and clinical improvement was obtained after an adequate microbiological procedure,
including an optimal sampling and an antimicrobial-susceptibility testing report.
Conclusion. Nocardia identification to the species level and performance of antimicrobial-susceptibility tests are both
essential tools for treatment adjustment and clinical improvement.
INTRODUCTION
Nocardia species can cause infections in immunocompetent
and immunocompromised patients, usually by inhalation
from environmental sources, and lung disease is the most
reported clinical form [1]. We present a clinical case of
endophthalmitis by Nocardia nova sensu stricto in an
immunocompetent male with a history of penetrating ocu-
lar trauma more than a year before. We argue that it is pos-
sible that the Nocardia micro-organism was present in
superficial ocular lesions, before the endophthalmitis mani-
fested a year later, and so its presence was not detected in
the microbiological culture of the superficial samples (ocu-
lar smears and corneal scrapings) due to the short period of
incubation, the presence of mixed flora, the previous use of
antibiotics or an inadequate sample collection. By present-
ing this case, we want to reinforce the importance of a good
communication between clinical practitioners and microbi-
ological staff to obtain an adequate sample and the most
precise diagnosis.
Moreover, as we confirm with this clinical picture, treat-
ment of Nocardia infections should be individualized, so
correct identification and antimicrobial-susceptibility test-
ing are critical [1]. Recent incorporation of more advanced
identification methods offers an opportunity for rapid and
correct identification at the species level [2], which favours
a more adequate therapy.
CASE REPORT
A 66-year-old man presented to the hospital emergency
department in August 2014 complaining of redness and
pain in his left eye, with blurred vision. His past medical his-
tory revealed no human immunodeficiency virus infection
or other immunodeficiency disorders. The patient reported
a history of perforating trauma to his left eye with a splinter
of a plastic hose while working in the countryside. On
examination, a central corneal wound was detected, which
was self-sealing but opened up to pressure. A positive Tyn-
dall effect was also observed. Topical (0.5 % moxifloxacin
1 eye drop/5 h) and oral (ciprofloxacin, 500 mg/8 h))
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antibiotics were prescribed for the following 6 months.
Intravenous (IV) vancomycin (1 g/12 h) and ceftazidime
(1 g/8 h) treatment was administered for 6 weeks. Samples
of corneal scrapings and conjunctival smears sent to the
microbiology department yielded no relevant results, and an
anatomopathological study of the cornea did not present
conclusive data. Given the torpid evolution, a cornea trans-
plant was finally performed in June 2015.
The patient was admitted again to the hospital on Novem-
ber 2015 due to an endophthalmitis in his left eye, despite
having been treated with 0.5 %moxifloxacin and 0.1 % dexa-
methasone drops since the cornea transplant. IV vancomy-
cin (1 g/12 h) and ceftazidime (1 g/8 h) were prescribed, in
addition to topical (1% drop/2 h) and oral
voriconazole (200 mg/12 h). An aspiration from the anterior
chamber of the eye was performed, and an aqueous humour
sample was sent to the microbiology department. Bacterial
culture was performed on Columbia blood agar, chocolate
agar, McConkey agar and in thioglycolate broth with incu-
bation at 35±2

C in atmospheric conditions supplemented
with 5% CO2. After 72 h, slightly whitish dry-looking colo-
nies were observed on blood agar and on chocolate agar
(Fig. 1). Gram staining yielded branched Gram-positive
rods, and modified Ziehl–Neelsen stain revealed acid-fast-
ness. The micro-organism was initially identified as Nocar-
dia asteroides (99.9% identity) using matrix-assisted laser
desorption/ionization-time of flight (MALDI-TOF) MS
(Vitek MS; bioMerieux). Sequencing of the 16S rRNA gene
and analysis using BLAST (http://www.ncbi.nlm.nih.gov)
showed 99.9% similarity to N. nova ATCC 33726 (GenBank
accession number: NR115835.1). Subsequently, applying an
updated software version for the MALDI-TOF MS, the iso-
late was identified as Nocardia africana/N. nova. Antimicro-
bial-susceptibility testing was performed using Etest strips
(bioMerieux) [3] and susceptibility clinical categories were
defined according to Clinical and Laboratory Standards
Institute (CLSI) guidelines for mycobacteria, nocardiae and
other actinomycetes [4]. The micro-organism was reported
as susceptible to ceftriaxone (MIC=0.5mg l 1), imipenem
(0.02mg l 1), amikacin (1mg l 1), clarithromycin (0.03mg
l 1) and linezolid (0.016mg l 1), and resistant to benzyl-
penicillin (>32mg l 1), amoxicillin-clavulanic acid
(>256mg l 1), tobramycin (128mg l 1), ciprofloxacin
(>32mg l 1), moxifloxacin (8mg l 1) and co-trimoxazole
(>32mg l 1). Although no susceptibility breakpoints have
been established for vancomycin by CLSI, the MIC value
was high (8mg l 1).
After the microbiological diagnosis of endophthalmitis
caused by N. nova, the patient was prescribed amikacin, 1 g/
24 h/IV, and imipenem, 500mg/6 h/IV, for 2months and
discharged. Treatment was continued with ambulatory ami-
kacin, 1 g/24 h/IV, and ceftriaxone, 2 g/24 h/IV, for 1 month;
linezolid, 600mg/12 h/orally for another month; and clari-
thromycin, 500mg/12 h/orally for 2 more months (total
Fig. 1. Strain morphology after 72 h incubation. (a) Blood agar (viewed with a magnifying glass, 40 magnification). (b) Gram
stain (x100 magnification). (c) Ziehl–Neelsen stain (x100 magnification).
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treatment time: 6months). The patient was followed-up
with consultations with the ophthalmology and infectious
diseases departments for 2 years, and satisfactory evolution
was observed.
DISCUSSION
N. nova complex (including the species: N. nova sensu
stricto, N. africana, Nocardia aobensis, Nocardia elegans,
Nocardia kruczakiae and Nocardia veterana) has been asso-
ciated with infections in both immunocompetent and
immunocompromised patients. In a recent review, it was
reported as the second most prevalent Nocardia species
recovered in clinical samples from Spain [5]. It can affect
the skin and soft tissues [6], respiratory system [7], bones
and joints [8], circulatory system [9], and central nervous
system [10]. Ocular infections such as keratitis, scleritis,
conjunctivitis, dacryocystitis, orbital cellulitis and endoph-
thalmitis due to Nocardia spp. are infrequently reported
[11–13] and usually described after penetrating corneal
trauma or ocular contact with plants and soils. They are
characterized by loss of vision, eye discomfort or pain, and
small whitish lesions in the case of keratitis [12].
Although is not possible to elucidate whether the endoph-
thalmitis in this case had surgical (5months before) or trau-
matic (1 year before) origin, we consider the last option as
the most probable due to the persistent symptoms since the
beginning. The use of different antimicrobial agents (moxi-
floxacin, ciprofloxacin, gentamicin, vancomycin and vorico-
nazole), to which the micro-organism is reported to be
resistant, before the definitive microbiological diagnosis
Fig. 2. Susceptibility to amoxicillin (AC) and resistance to amoxicillin-clavulanic acid (AUG) (inducible b-lactamase).
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could support this assertion in the clinical picture. The
infection was resolved only when an adequate antimicrobial
therapy was administered more than 1 year later. Is it possi-
ble that the Nocardia isolate was present in the first months?
If so, why was the micro-organism not detected in conven-
tional culture? A plausible reason is the type of sample sent
to the laboratory, consisting of superficial samples such con-
junctival smears and corneal scrapings. In the case of con-
junctival smears, the incubation time approved in our
procedures for the conventional culture of conjunctival
samples is only 48 h, as long as no relevant comments are
reflected on the microbiological request. Corneal scraping is
a good sample, but its sensitivity is not always optimal, espe-
cially in patients with deep-seated keratitis, and depends on
the amount of sample collected and the location. Moreover,
usually the inoculum in corneal sample is so low that it is
affected by the presence of topical antibiotics, reducing bac-
terial culture sensitivity significantly. However, when the
infection evolved to a more severe and evident endophthal-
mitis, and an aqueous humour sample was obtained, the
causative agent could be diagnosed and adequate therapy
initiated. Based on this case, we suggest a prolonged incuba-
tion time for samples related to ocular trauma infections
and contact with the microbiologist in case of negative cul-
tures/results.
Although microbiological identification of the genus Nocar-
dia is usually easy to perform, accurate species identification
following standard protocols is difficult. In our case, defini-
tive identification was performed by sequencing the 16S
rRNA gene. However, in order to evaluate MALDI-TOF MS
as a new diagnostic tool, two different MALDI-TOF MS
software versions were used. At the time of micro-organism
identification in the clinical case, the MALDI-TOF MS soft-
ware version (Vitek MS v2) only included N. asteroides
identification within the genus Nocardia. The current soft-
ware version recently available in our
Microbiology laboratory (Vitek MS v3) includes Nocardia
abscessus, N. africana/N. nova, Nocardia beijingensis, Nocar-
dia brasiliensis, Nocardia cyriacigeorgica, Nocardia farcinica,
Nocardia neocaledoniensis, Nocardia otitidiscaviarum,
Nocardia paucivorans, Nocardia pseudobrasiliensis, Nocar-
dia transvalensis and N. veterana. Applying this latest soft-
ware, the strain (previously stored by freezing) was
identified as N. nova/N. africana. Continuous updating of
databases supports and reinforces MALDI-TOF MS tech-
nology as a promising tool for identifying actinomycete
micro-organisms.
N. nova complex presents the susceptibility pattern
described for the N. asteroides pharmacological group III,
characterized by susceptibility to amoxicillin but resistance
to amoxicillin-clavulanic acid (b-lactamase inducible by
clavulanic acid), and susceptibility to erythromycin, amika-
cin, ceftriaxone and linezolid [14]. Fluoroquinolone resis-
tance is common. This characteristic susceptibility pattern
matched completely with our micro-organism (Fig. 2).
The treatment of infection by N. nova often requires the
combination of systemic antibiotic therapy and surgical
management [6, 8]. IV antibiotic agents should be initially
administered for 6–8weeks, preferably with two antimicro-
bials with confirmed in vitro susceptibility, including co-tri-
moxazole [7]. Because of possible resistance to this last
compound [14], as in the case we report, the combination
of co-trimoxazole, amikacin and ceftriaxone or imipenem
has been recommended [8, 12] for empirical treatment.
Once co-trimoxazole susceptibility is confirmed by a labora-
tory, it is possible to continue with oral co-trimoxazole
monotherapy for at least 3–6months, depending on the
focus of infection and the immune status of the patient.
Oral alternatives, such as macrolides and linezolid [5], have
also been reported.
It is a recognized fact that infections caused by these micro-
organisms pose diagnostic and therapeutic challenges. A
high degree of clinical suspicion will help early diagnosis by
microbiologists and the administration of appropriate
therapy.
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